UBS Group
STAA icon

UBS Group’s STAAR Surgical STAA Stock Holding History

UBS Group’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-127,074
Closed -$3.97M – 9986
2023
Q4 		$3.97M Buy
+127,074
New +$4.57M ﹤0.01% 3027
2015
Q1 		– Sell
-400
Closed -$4K – 9345
2014
Q4 		$4K Buy
+400
New +$3.87K ﹤0.01% 9129

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group's STAA Position: Q1 2026 in Review

UBS Group reduced its STAAR Surgical (STAA) stake by 45% in Q1 2026, selling an estimated $2.82M and leaving 179,929 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #4472.

UBS Group first reported a position in STAA in Q4 2014 and has held it in 46 quarters since. The position peaked at $7.57M in Q4 2025. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • UBS Group held 179,929 shares of STAAR Surgical worth $3.36M as of Q1 2026.
  • UBS Group sold 147,923 STAAR Surgical shares in Q1 2026, an estimated $2.82M.
  • STAAR Surgical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4472 holding.
  • UBS Group first reported a position in STAAR Surgical in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's STAAR Surgical position peaked at $7.57M in Q4 2025.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.